Endpoints PodcastEndpoints Podcast

Copper Complexes: Dr. Fernando Vieira on ALS TDI's Promising Potential ALS Treatment

View descriptionShare

Endpoints

The Endpoints Podcast features guests from the ALS community, including people living with ALS, researchers, advocates and fundraisers. Each episode c 
58 clip(s)
Loading playlist

ALS TDI’s primary mission is to discover treatments for everyone with ALS. Every day, our scientists are testing drugs to find the next compound with the potential to make it to clinical trials and beyond. Currently, one of our most promising leads is a group of molecules called copper complexes.

These copper complexes, also referred to as redox metabolism modulators, have demonstrated signs of efficacy in ALS TDI’s cellular and animal models of ALS. Currently, our scientists are hard at work looking for a lead molecule to advance toward clinical trials.

Today, on Endpoints, we’re joined by Dr. Fernando Vieira, ALS TDI’s CEO and CSO, to tell us more about what copper complexes are, how ALS TDI discovered their potential for treating ALS, and where they are in the drug development process.

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Endpoints

    58 clip(s)

Endpoints Podcast

The Endpoints Podcast features guests from the ALS community, including people living with ALS, rese 
Social links
Follow podcast
Recent clips
Browse 63 clip(s)